Healthcare IT Today December 27, 2023
New Funds to Fortify US Market Entry and Growth Strategy, as well as Advance Breakthrough Research
Biorithm, a global women’s health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. With a homegrown spirit and a global vision, Biorithm is dedicated to developing cutting-edge solutions for personalized connected maternity care. The funding will fuel Biorithm’s expansion in Southeast Asia and the United States. It also will assist the company in advancing Femom, a comprehensive obstetric remote monitoring solution, and completing clinical studies to support a 510(K) premarket submission to the US Food and Drug Administration.
Complications from childbirth result in mortality for 800 women every day. Biorithm is committed to ending preventable...
Today's Sponsors
Today's Sponsor
